Aditya Birla Sun Life Pharma & Healthcare Fund
An open ended equity scheme investing in Pharma and Healthcare Services Sector
June 2026
| Equity Scheme |  |
 |
 |
 |
An open ended equity scheme investing in Pharma and Healthcare Services Sector
June 2026
| Equity Scheme | |
|
|
|
| Investment Objective | |
| The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There is no assurance that the objective of the Scheme will be achieved | |
| Fund Category: Sectoral/Thematic | |
 |
|
| Fund Snapshot | |
| Date of Allotment : Jul 11, 2019 | |
| Benchmark: BSE Healthcare TRI | |
| Fund Manager -Mr. Dhaval Shah Managing the Fund Since: July 11, 2019 Experience in Managing the Fund: 7.0 Years |
|
| SIP: Daily/Weekly/Monthly: Minimum ₹ 100/-and in multiples of ₹ 1/- thereafter |
|
| Application Amount for fresh subscription: ₹ 1000 (plus in multiplies of ₹ 1) |
|
| Minimum Additional Investment: ₹ 1000 (plus in multiplies of ₹ 1) |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | For redemption/switch-out of units on or before 30 days from the date of allotment:1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil |
| Count of Securities: 38 | |
| AUM as on June 30, 2026 (in ₹Crore) | |
| Month End AUM | 1,010.54 |
| Monthly Average AUM | 973.17 |
| Base Expense Ratio (BER) | |
| Regular | 1.92% |
| Direct | 0.82% |
| BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors. | |
| NAV as on June 30, 2026 | |
| Regular Growth | 34.85 |
| Regular IDCW$ | 23.01 |
| Direct Growth | 38.75 |
| Direct IDCW$ | 25.19 |
| $Income Distribution cum capital withdrawal | |
| Valuation Parameters | |
| Average P/E | 40 |
| Average P/BV | 6.63 |
| Average Dividend Yield | 0.73 |
| Sectoral Contribution(in %) |
 |
| Market Capitalisation |
 |
| Volatility Measures | |
| Portfolio Turnover | 0.22 |
| Standard Deviation | 15.68% |
| Sharpe Ratio | 1.07 |
| Beta | 0.91 |
| Treynor Ratio | 0.19 |
| Information Ratio | -0.50 |
Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk FreeRate assumed tobe 5.50%(FBIL OvernightMIBOR as on 30 June, 2026) for calculating SharpeRatio
| Rating Profile of Portfolio |  |
| Sector/Issuer Name | % of Net AUM |
| Equity & Equity Related | |
| Pharmaceuticals & Biotechnology | 75.20 % |
| ● Sun Pharmaceutical Industries Ltd. | 12.09 % |
| ● J.B. Chemicals & Pharmaceuticals Ltd. | 4.71 % |
| ● Torrent Pharmaceuticals Ltd. | 4.68 % |
| ● Aurobindo Pharma Ltd. | 4.55 % |
| ● Ajanta Pharmaceuticals Ltd. | 4.38 % |
| ● Mankind Pharma Ltd. | 3.92 % |
| ● Lupin Ltd. | 3.74 % |
| ● Sai Life Sciences Ltd. | 3.50 % |
| ● Abbott India Ltd. | 3.26 % |
| Emcure Pharmaceuticals Ltd. | 3.23 % |
| Cipla Ltd. | 2.93 % |
| Ipca Laboratories Ltd. | 2.55 % |
| Gland Pharma Ltd. | 2.48 % |
| Shilpa Medicare Ltd. | 2.41 % |
| CORONA Remedies Ltd. | 2.28 % |
| Procter & Gamble Health Ltd. | 2.20 % |
| Alkem Laboratories Ltd. | 1.93 % |
| Divi''s Laboratories Ltd. | 1.69 % |
| Sanofi Consumer Healthcare India Ltd. | 1.44 % |
| Dr. Reddy''s Laboratories Ltd. | 1.33 % |
| Pfizer Ltd. | 1.23 % |
| Biocon Ltd. | 1.12 % |
| Anthem Biosciences Ltd. | 1.08 % |
| Piramal Pharma Ltd. | 1.06 % |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.79 % |
| Jubilant Pharmova Ltd. | 0.61 % |
| Healthcare Services | 20.87 % |
| ● Apollo Hospitals Enterprise Ltd. | 7.30 % |
| Fortis Healthcare Ltd. | 3.21 % |
| Thyrocare Technologies Ltd. | 1.93 % |
| Jupiter Life Line Hospitals Ltd. | 1.85 % |
| Dr. Lal Path Labs Ltd. | 1.59 % |
| Metropolis Healthcare Ltd. | 1.44 % |
| Vijaya Diagnostic Centre Ltd. | 1.05 % |
| Suraksha Diagnostic Ltd. | 0.90 % |
| Syngene International Ltd. | 0.82 % |
| Max Healthcare Institute Ltd. | 0.78 % |
| Insurance | 0.95 % |
| Medi Assist Healthcare Services Ltd. | 0.95 % |
| Chemicals & Petrochemicals | 0.85 % |
| Vinati Organics Ltd. | 0.85 % |
| Net Cash and Cash Equivalent | 2.15 % |
| Grand Total | 100.00 % |
Miscellaneous includes securities with exposure of less than 0.01%
| Scheme Name | |
| Aditya Birla Sun Life Pharma & Healthcare Fund An open ended equity scheme investing in Pharma and Healthcare Services Sector |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter  |
Benchmark Risk-o-meter BSE Healthcare TRI  |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |